Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
Condition: ObesityInterventions: Drug: Canagliflozin; Drug: Phentermine; Drug: Matching Placebo to Canagliflozin; Drug: Matching Placebo to PhentermineSponsor: Janssen Research & Development, LLCRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2014 Category: Research Source Type: clinical trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
Condition: ObesityInterventions: Drug: Canagliflozin; Drug: Phentermine; Drug: Matching Placebo to Canagliflozin; Drug: Matching Placebo to PhentermineSponsor: Janssen Research & Development, LLCRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2014 Category: Research Source Type: clinical trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
Condition: ObesityInterventions: Drug: Canagliflozin; Drug: Phentermine; Drug: Matching Placebo to Canagliflozin; Drug: Matching Placebo to PhentermineSponsor: Janssen Research & Development, LLCRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2014 Category: Research Source Type: clinical trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
Condition: ObesityInterventions: Drug: Canagliflozin; Drug: Phentermine; Drug: Matching Placebo to Canagliflozin; Drug: Matching Placebo to PhentermineSponsor: Janssen Research & Development, LLCRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2014 Category: Research Source Type: clinical trials